Risk of Hepatitis B Reactivation Among ALL Patients With Occult Hepatitis B Infection
{{output}}
Purpose: Anticancer therapy increases the risk of hepatitis B virus (HBV) reactivation in patients with occult hepatitis B infection (OHBI), particularly in those who receive rituximab or stem-cell transplantation. However, the e... ...
